Epsilon Healthcare Ltd
OTC:HDRPF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Epsilon Healthcare Ltd
OTC:HDRPF
|
AU |
|
AlzChem Group AG
XETRA:ACT
|
DE |
|
Ur-Energy Inc
TSX:URE
|
US |
|
Emperor Watch & Jewellery Ltd
HKEX:887
|
HK |
|
C
|
CviLux Corp
TWSE:8103
|
TW |
|
Impact Healthcare REIT PLC
LSE:IHR
|
UK |
Income Statement
Earnings Waterfall
Epsilon Healthcare Ltd
Income Statement
Epsilon Healthcare Ltd
| Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Interest Expense |
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
6
N/A
|
7
+13%
|
7
-3%
|
5
-18%
|
5
-1%
|
5
-15%
|
5
+2%
|
7
+40%
|
6
-7%
|
6
-10%
|
6
+10%
|
9
+53%
|
|
| Gross Profit | |||||||||||||
| Cost of Revenue |
(5)
|
(5)
|
(4)
|
(4)
|
(4)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
(3)
|
(4)
|
|
| Gross Profit |
1
N/A
|
2
+85%
|
2
+2%
|
2
-19%
|
2
-2%
|
1
-34%
|
3
+121%
|
5
+77%
|
5
+0%
|
4
-13%
|
3
-23%
|
6
+76%
|
|
| Operating Income | |||||||||||||
| Operating Expenses |
(13)
|
(13)
|
(13)
|
(11)
|
(8)
|
(8)
|
(7)
|
(7)
|
(8)
|
(9)
|
(9)
|
(8)
|
|
| Selling, General & Administrative |
(11)
|
(11)
|
(12)
|
(10)
|
(7)
|
(6)
|
(5)
|
(6)
|
(7)
|
(7)
|
(8)
|
(7)
|
|
| Research & Development |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
(0)
|
|
| Operating Income |
(12)
N/A
|
(11)
+6%
|
(11)
-2%
|
(9)
+16%
|
(6)
+33%
|
(6)
-5%
|
(4)
+34%
|
(2)
+43%
|
(3)
-35%
|
(5)
-51%
|
(6)
-18%
|
(2)
+62%
|
|
| Pre-Tax Income | |||||||||||||
| Interest Income Expense |
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Non-Reccuring Items |
(0)
|
0
|
(0)
|
(3)
|
(8)
|
(9)
|
(3)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
1
|
2
|
2
|
2
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Pre-Tax Income |
(12)
N/A
|
(11)
+9%
|
(10)
+9%
|
(10)
-6%
|
(14)
-35%
|
(14)
-4%
|
(7)
+52%
|
(3)
+51%
|
(4)
-35%
|
(6)
-26%
|
(7)
-21%
|
(3)
+56%
|
|
| Net Income | |||||||||||||
| Tax Provision |
0
|
0
|
0
|
1
|
0
|
1
|
1
|
2
|
3
|
0
|
1
|
1
|
|
| Income from Continuing Operations |
(12)
|
(11)
|
(9)
|
(9)
|
(13)
|
(14)
|
(6)
|
(1)
|
(2)
|
(5)
|
(6)
|
(2)
|
|
| Net Income (Common) |
(12)
N/A
|
(11)
+9%
|
(9)
+13%
|
(9)
-1%
|
(13)
-43%
|
(14)
-3%
|
(6)
+54%
|
(1)
+83%
|
(2)
-66%
|
(5)
-203%
|
(6)
-11%
|
(2)
+67%
|
|
| EPS (Diluted) |
-0.08
N/A
|
-0.07
+12%
|
-0.05
+29%
|
-0.05
N/A
|
-0.06
-20%
|
-0.05
+17%
|
-0.02
+60%
|
0
N/A
|
-0.01
N/A
|
-0.02
-100%
|
-0.02
N/A
|
-0.01
+50%
|
|